kyse450 Search Results


kyse450  (DSMZ)
94
DSMZ kyse450
Compound 91b1 downregulates the expression of CCL5 in ESCC cell lines. CCL5 mRNA expression levels in ESCC cell lines (A) KYSE150, (B) <t>KYSE450,</t> (C) KYSE510 and (D) HKESC-4 after 48-h treatment of 91b1 in different concentrations. Each test was performed in triplicate and relative CCL5 expression levels were determined by comparing with cells treated with vehicle DMSO (0.05%) following normalized with the expression of β-actin. CCL5 protein expression of (E) KYSE150, (F) KYSE450, (G) KYSE510 and (H) HKESC-4 after 48-h treatment of 91b1 in different concentrations vs. vehicle. Each assay was performed in triplicate. (I) Immunohistochemical staining of CCL5 for KYSE150 treated with vehicle control (DMSO), 6.5, 9.5 and 21 μ g/ml 91b1 for 48 h; original magnification, ×400; (J) The staining signals were quantitatively analyzed by ImageJ (National Institutes of Health). * P<0.05; ** P<0.01; ns, not significant. CCL5, chemokine (C-C motif) ligand 5; ESCC, esophageal squamous cell carcinoma.
Kyse450, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kyse450/KYSE-450/pmc11517744-79-11-21
Average 94 stars, based on 1 article reviews
kyse450 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
human escc cell lines kyse450  (iCell Bioscience Inc)
90
iCell Bioscience Inc human escc cell lines kyse450
Construction of a risk signature using the least absolute shrinkage and selection operator (LASSO) analysis. Partial likelihood deviances for (A) oesophageal squamous cell carcinoma <t>(ESCC)</t> and (B) oesophageal adenocarcinoma (EAC). Coefficient profiles of senescence‐related gene pairs for (C) <t>ESCC</t> and (D) EAC.
Human Escc Cell Lines Kyse450, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kyse450/human+escc+cell+lines+kyse450/pmc11850095-90-0-20
Average 90 stars, based on 1 article reviews
human escc cell lines kyse450 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
kyse450 str amelogenin  (VivaCell Biotechnology GmbH)
90
VivaCell Biotechnology GmbH kyse450 str amelogenin
Construction of a risk signature using the least absolute shrinkage and selection operator (LASSO) analysis. Partial likelihood deviances for (A) oesophageal squamous cell carcinoma <t>(ESCC)</t> and (B) oesophageal adenocarcinoma (EAC). Coefficient profiles of senescence‐related gene pairs for (C) <t>ESCC</t> and (D) EAC.
Kyse450 Str Amelogenin, supplied by VivaCell Biotechnology GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kyse450/kyse450+str+amelogenin/pmc10518355__mmc5-1135-6-14
Average 90 stars, based on 1 article reviews
kyse450 str amelogenin - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cell lines kyse450  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare cell lines kyse450
Construction of a risk signature using the least absolute shrinkage and selection operator (LASSO) analysis. Partial likelihood deviances for (A) oesophageal squamous cell carcinoma <t>(ESCC)</t> and (B) oesophageal adenocarcinoma (EAC). Coefficient profiles of senescence‐related gene pairs for (C) <t>ESCC</t> and (D) EAC.
Cell Lines Kyse450, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kyse450/cell+lines+kyse450/pm16823849-117-18-8
Average 90 stars, based on 1 article reviews
cell lines kyse450 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
kyse450  (YUTAKA Engineering Corporation)
90
YUTAKA Engineering Corporation kyse450
Construction of a risk signature using the least absolute shrinkage and selection operator (LASSO) analysis. Partial likelihood deviances for (A) oesophageal squamous cell carcinoma <t>(ESCC)</t> and (B) oesophageal adenocarcinoma (EAC). Coefficient profiles of senescence‐related gene pairs for (C) <t>ESCC</t> and (D) EAC.
Kyse450, supplied by YUTAKA Engineering Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kyse450/kyse450/pmc07944388-26-12-26
Average 90 stars, based on 1 article reviews
kyse450 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
kyse450  (BGI Shenzhen)
90
BGI Shenzhen kyse450
Construction of a risk signature using the least absolute shrinkage and selection operator (LASSO) analysis. Partial likelihood deviances for (A) oesophageal squamous cell carcinoma <t>(ESCC)</t> and (B) oesophageal adenocarcinoma (EAC). Coefficient profiles of senescence‐related gene pairs for (C) <t>ESCC</t> and (D) EAC.
Kyse450, supplied by BGI Shenzhen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kyse450/kyse450/pm38649419-138-18-20
Average 90 stars, based on 1 article reviews
kyse450 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ec cell line kyse-450  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection ec cell line kyse-450
Construction of a risk signature using the least absolute shrinkage and selection operator (LASSO) analysis. Partial likelihood deviances for (A) oesophageal squamous cell carcinoma <t>(ESCC)</t> and (B) oesophageal adenocarcinoma (EAC). Coefficient profiles of senescence‐related gene pairs for (C) <t>ESCC</t> and (D) EAC.
Ec Cell Line Kyse 450, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kyse450/ec+cell+line+kyse+450/pm37430202-80-0-8
Average 90 stars, based on 1 article reviews
ec cell line kyse-450 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Compound 91b1 downregulates the expression of CCL5 in ESCC cell lines. CCL5 mRNA expression levels in ESCC cell lines (A) KYSE150, (B) KYSE450, (C) KYSE510 and (D) HKESC-4 after 48-h treatment of 91b1 in different concentrations. Each test was performed in triplicate and relative CCL5 expression levels were determined by comparing with cells treated with vehicle DMSO (0.05%) following normalized with the expression of β-actin. CCL5 protein expression of (E) KYSE150, (F) KYSE450, (G) KYSE510 and (H) HKESC-4 after 48-h treatment of 91b1 in different concentrations vs. vehicle. Each assay was performed in triplicate. (I) Immunohistochemical staining of CCL5 for KYSE150 treated with vehicle control (DMSO), 6.5, 9.5 and 21 μ g/ml 91b1 for 48 h; original magnification, ×400; (J) The staining signals were quantitatively analyzed by ImageJ (National Institutes of Health). * P<0.05; ** P<0.01; ns, not significant. CCL5, chemokine (C-C motif) ligand 5; ESCC, esophageal squamous cell carcinoma.

Journal: International Journal of Molecular Medicine

Article Title: Downregulation of chemokine (C-C motif) ligand 5 induced by a novel 8-hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma

doi: 10.3892/ijmm.2024.5435

Figure Lengend Snippet: Compound 91b1 downregulates the expression of CCL5 in ESCC cell lines. CCL5 mRNA expression levels in ESCC cell lines (A) KYSE150, (B) KYSE450, (C) KYSE510 and (D) HKESC-4 after 48-h treatment of 91b1 in different concentrations. Each test was performed in triplicate and relative CCL5 expression levels were determined by comparing with cells treated with vehicle DMSO (0.05%) following normalized with the expression of β-actin. CCL5 protein expression of (E) KYSE150, (F) KYSE450, (G) KYSE510 and (H) HKESC-4 after 48-h treatment of 91b1 in different concentrations vs. vehicle. Each assay was performed in triplicate. (I) Immunohistochemical staining of CCL5 for KYSE150 treated with vehicle control (DMSO), 6.5, 9.5 and 21 μ g/ml 91b1 for 48 h; original magnification, ×400; (J) The staining signals were quantitatively analyzed by ImageJ (National Institutes of Health). * P<0.05; ** P<0.01; ns, not significant. CCL5, chemokine (C-C motif) ligand 5; ESCC, esophageal squamous cell carcinoma.

Article Snippet: Esophageal squamous cell carcinoma (ESCC) cell lines of Japanese origin KYSE150, KYSE450, KYSE30 and KYSE510 ( ) were purchased from Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH.

Techniques: Expressing, Immunohistochemical staining, Staining, Control

Compound 91b1 shows stronger cytotoxic effect in ESCC cell lines and less cytotoxic effect in non-neoplastic cells. Cytotoxic effects of 91b1 on ESCC cell lines (A) KYSE30, (B) KYSE150, (C) KYSE450, and (D) HKESC-4; and non-neoplastic cell lines (E) NE-3 and (F) 293 were examined by MTS cytotoxicity assay with CDDP as the positive control. Each test was performed in triplicate. ESCC, esophageal squamous cell carcinoma; MTS, [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium]; CDDP, cisplatin.

Journal: International Journal of Molecular Medicine

Article Title: Downregulation of chemokine (C-C motif) ligand 5 induced by a novel 8-hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma

doi: 10.3892/ijmm.2024.5435

Figure Lengend Snippet: Compound 91b1 shows stronger cytotoxic effect in ESCC cell lines and less cytotoxic effect in non-neoplastic cells. Cytotoxic effects of 91b1 on ESCC cell lines (A) KYSE30, (B) KYSE150, (C) KYSE450, and (D) HKESC-4; and non-neoplastic cell lines (E) NE-3 and (F) 293 were examined by MTS cytotoxicity assay with CDDP as the positive control. Each test was performed in triplicate. ESCC, esophageal squamous cell carcinoma; MTS, [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium]; CDDP, cisplatin.

Article Snippet: Esophageal squamous cell carcinoma (ESCC) cell lines of Japanese origin KYSE150, KYSE450, KYSE30 and KYSE510 ( ) were purchased from Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH.

Techniques: Cytotoxicity Assay, Positive Control

MTS 50 ( μ g/ml) of 91b1 and CDDP for four ESCC cell lines and two non-tumor cell lines. Results were expressed with mean ± SD from triplicate. experiments.

Journal: International Journal of Molecular Medicine

Article Title: Downregulation of chemokine (C-C motif) ligand 5 induced by a novel 8-hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma

doi: 10.3892/ijmm.2024.5435

Figure Lengend Snippet: MTS 50 ( μ g/ml) of 91b1 and CDDP for four ESCC cell lines and two non-tumor cell lines. Results were expressed with mean ± SD from triplicate. experiments.

Article Snippet: Esophageal squamous cell carcinoma (ESCC) cell lines of Japanese origin KYSE150, KYSE450, KYSE30 and KYSE510 ( ) were purchased from Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH.

Techniques:

Construction of a risk signature using the least absolute shrinkage and selection operator (LASSO) analysis. Partial likelihood deviances for (A) oesophageal squamous cell carcinoma (ESCC) and (B) oesophageal adenocarcinoma (EAC). Coefficient profiles of senescence‐related gene pairs for (C) ESCC and (D) EAC.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Multi‐Omics Analysis of Aberrances and Functional Implications of IRF5 in Digestive Tract Tumours

doi: 10.1111/jcmm.70433

Figure Lengend Snippet: Construction of a risk signature using the least absolute shrinkage and selection operator (LASSO) analysis. Partial likelihood deviances for (A) oesophageal squamous cell carcinoma (ESCC) and (B) oesophageal adenocarcinoma (EAC). Coefficient profiles of senescence‐related gene pairs for (C) ESCC and (D) EAC.

Article Snippet: Human ESCC cell lines (KYSE150, KYSE180, KYSE410 and KYSE450) and the human embryonic oesophageal cell line (SHEE) were purchased from iCell Bioscience Inc. (Shanghai, China).

Techniques: Selection

Kaplan–Meier analysis of high‐ and low‐risk patients (red and blue, respectively) with (A) oesophageal squamous cell carcinoma (ESCC) and (B) oesophageal adenocarcinoma (EAC). Receiver operating characteristic curves for (C) ESCC and (D) EAC. Survival risk curves (top) and sand scatter plots (bottom) for (E) ESCC and (F) EAC.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Multi‐Omics Analysis of Aberrances and Functional Implications of IRF5 in Digestive Tract Tumours

doi: 10.1111/jcmm.70433

Figure Lengend Snippet: Kaplan–Meier analysis of high‐ and low‐risk patients (red and blue, respectively) with (A) oesophageal squamous cell carcinoma (ESCC) and (B) oesophageal adenocarcinoma (EAC). Receiver operating characteristic curves for (C) ESCC and (D) EAC. Survival risk curves (top) and sand scatter plots (bottom) for (E) ESCC and (F) EAC.

Article Snippet: Human ESCC cell lines (KYSE150, KYSE180, KYSE410 and KYSE450) and the human embryonic oesophageal cell line (SHEE) were purchased from iCell Bioscience Inc. (Shanghai, China).

Techniques:

Correlations of immune microenvironments evaluated using ESTIMATE. (A) Immune score and (B) ESTIMATE score for oesophageal squamous cell carcinoma (ESCC). (C) Immune score and (D) ESTIMATE score for oesophageal adenocarcinoma (EAC). Relationships between risk and immune scores for (E) ESCC and (H) EAC. Relationships between risk and ESTIMATE scores for (F) ESCC and (G) EAC.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Multi‐Omics Analysis of Aberrances and Functional Implications of IRF5 in Digestive Tract Tumours

doi: 10.1111/jcmm.70433

Figure Lengend Snippet: Correlations of immune microenvironments evaluated using ESTIMATE. (A) Immune score and (B) ESTIMATE score for oesophageal squamous cell carcinoma (ESCC). (C) Immune score and (D) ESTIMATE score for oesophageal adenocarcinoma (EAC). Relationships between risk and immune scores for (E) ESCC and (H) EAC. Relationships between risk and ESTIMATE scores for (F) ESCC and (G) EAC.

Article Snippet: Human ESCC cell lines (KYSE150, KYSE180, KYSE410 and KYSE450) and the human embryonic oesophageal cell line (SHEE) were purchased from iCell Bioscience Inc. (Shanghai, China).

Techniques:

Random forest error rates (left graphs) and relative importance (right graphs) for (A) oesophageal squamous cell carcinoma (ESCC) and (B) oesophageal adenocarcinoma (EAC). Expression of IRF5 and BMI1 in (C) ESCC, (D) EAC and (E) EC.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Multi‐Omics Analysis of Aberrances and Functional Implications of IRF5 in Digestive Tract Tumours

doi: 10.1111/jcmm.70433

Figure Lengend Snippet: Random forest error rates (left graphs) and relative importance (right graphs) for (A) oesophageal squamous cell carcinoma (ESCC) and (B) oesophageal adenocarcinoma (EAC). Expression of IRF5 and BMI1 in (C) ESCC, (D) EAC and (E) EC.

Article Snippet: Human ESCC cell lines (KYSE150, KYSE180, KYSE410 and KYSE450) and the human embryonic oesophageal cell line (SHEE) were purchased from iCell Bioscience Inc. (Shanghai, China).

Techniques: Expressing

Expression analyses of IRF5 in four ESCC cell lines using western blotting (A, B). The efficiency of IRF5 ‐knockdown in KYSE150 cells was determined using western blotting (C, D). Ctrl: No siRNA infection; NC: Negative control. Statistical analyses of n = 3 independent experiments were assessed. Results are shown as mean ± SD, ns p ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Journal of Cellular and Molecular Medicine

Article Title: Multi‐Omics Analysis of Aberrances and Functional Implications of IRF5 in Digestive Tract Tumours

doi: 10.1111/jcmm.70433

Figure Lengend Snippet: Expression analyses of IRF5 in four ESCC cell lines using western blotting (A, B). The efficiency of IRF5 ‐knockdown in KYSE150 cells was determined using western blotting (C, D). Ctrl: No siRNA infection; NC: Negative control. Statistical analyses of n = 3 independent experiments were assessed. Results are shown as mean ± SD, ns p ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Human ESCC cell lines (KYSE150, KYSE180, KYSE410 and KYSE450) and the human embryonic oesophageal cell line (SHEE) were purchased from iCell Bioscience Inc. (Shanghai, China).

Techniques: Expressing, Western Blot, Knockdown, Infection, Negative Control